Shares of Herbalife Ltd. (NYSE:HLF - Get Free Report) have been given an average recommendation of "Hold" by the five brokerages that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $9.90.
Several research firms have recently commented on HLF. Citigroup cut their price target on Herbalife from $16.00 to $13.00 and set a "buy" rating for the company in a research note on Friday, October 25th. StockNews.com raised Herbalife from a "hold" rating to a "buy" rating in a research note on Monday, November 4th. DA Davidson dropped their price target on Herbalife from $13.00 to $7.50 and set a "neutral" rating for the company in a research report on Thursday, October 31st. B. Riley dropped their price target on Herbalife from $17.00 to $12.00 and set a "buy" rating for the company in a research report on Thursday, October 31st. Finally, Mizuho raised their price objective on shares of Herbalife from $8.00 to $9.00 and gave the stock a "neutral" rating in a research note on Friday, November 1st.
Check Out Our Latest Analysis on HLF
Herbalife Trading Down 4.5 %
Shares of Herbalife stock traded down $0.26 on Friday, hitting $5.45. The stock had a trading volume of 3,137,842 shares, compared to its average volume of 1,876,589. Herbalife has a 52-week low of $5.41 and a 52-week high of $12.81. The stock has a market cap of $548.80 million, a price-to-earnings ratio of 6.41, a P/E/G ratio of 0.19 and a beta of 1.18. The company's 50 day moving average price is $7.04 and its 200 day moving average price is $7.89.
Herbalife (NYSE:HLF - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.19 by $0.38. Herbalife had a net margin of 1.73% and a negative return on equity of 18.66%. The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.23 billion. Analysts predict that Herbalife will post 1.51 EPS for the current fiscal year.
Institutional Trading of Herbalife
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Bank of Montreal Can increased its holdings in shares of Herbalife by 15.3% in the 2nd quarter. Bank of Montreal Can now owns 3,776,641 shares of the company's stock valued at $41,354,000 after acquiring an additional 500,876 shares during the last quarter. Long Focus Capital Management LLC raised its position in Herbalife by 11.3% in the second quarter. Long Focus Capital Management LLC now owns 3,202,982 shares of the company's stock worth $33,279,000 after acquiring an additional 323,969 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Herbalife by 4.2% in the third quarter. Geode Capital Management LLC now owns 2,615,514 shares of the company's stock valued at $18,809,000 after buying an additional 105,431 shares in the last quarter. Iridian Asset Management LLC CT raised its position in shares of Herbalife by 12.5% during the fourth quarter. Iridian Asset Management LLC CT now owns 2,507,740 shares of the company's stock worth $16,777,000 after purchasing an additional 279,547 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Herbalife by 6.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,479,957 shares of the company's stock valued at $17,831,000 after acquiring an additional 160,792 shares during the period.
Herbalife Company Profile
(
Get Free ReportHerbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Recommended Stories
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
